UCIdidmyDD
Posted - 1 month ago
$AXIM gl Catalina. its ridiculous that JOhn was allowed to keep his job after his multiple public gaffes on Covid, in interviews. making 35k a month while he fucked up everything he touched. like so many, alcohol seemed to be his downfall. may his loved ones find peace where his investors found a different horror show sorry i dont have a filter
TexasMarvL
Posted - 1 month ago
$AXIM AXIM Insiders still control the AXIM Intellectual property. I would be curious to watch from a distance if Verséa Ophthalmics is able to join or merge as part owner. However it doesn't seem to matter anymore for the retail investor. The price keeps falling. Maybe that is the plan.
It probably makes sense for Verséa to let AXIM go bankrupt and then negotiate a deal with the insiders to take the company private. I will watch from a distance to see what happens.
I have always had a positive impression about Catalina Valencia. She must have bought Mr Huemoeller's shares today. It appears she paid way too much for over a million shares today.
She paid $28,608.22 for 1,086,216 shares which is 0.0263 per share. She could have bought the same number of shares for $2172.43 today. The only explanation I can think of is she bought the shares from Mr Huemoeller's family. RIP Mr Huemoeller.
TexasMarvL
Posted - 1 month ago
$AXIM Form 8-K
RIP CEO Mr John Huemoeller. Catalina Valencia, 75, replaces Mr Huemoeller as CEO.
insiderbuyingselling
Posted - 1 month ago
$AXIM new insider buying: 1086216 shares. http://insiderbuyingselling.com/?t=AXIM
TexasMarvL
Posted - 1 month ago
$AXIM Is Website shut down?
WWW.AXIMEYE.COM
This one still works.
https://aximbiotech.com/
TexasMarvL
Posted - 2 months ago
$AXIM Q2 results were a total disaster. Only 1000 tests were sold in Q2 after almost 5000 sold in Q1. On Page 28 of Q2 10-Q go to the bottom and read the last paragraph. Since production started I have only focused on revenue. Last time AXIM management was this quiet they had apparently screwed up manufacturing and after 5 months of silence hired contract manufacturer Auer Precision at the end of December. Auer Precision was a great decision. Q1 sales were very promising. Then the announcement about the Parkinsons disease test. Then absolutely nothing. The Parkinsons disease test was barely mentioned in the Q2 10-Q. I have no clue what AXIM management has screwed up this time. Only 1000 tests sold in Q2. Verséa Ophthalmics new customer announcements on LinkedIn have dropped from one every week to maybe one a month. When AXIM management is this quiet, my guess is they screwed something up.
Glopez87
Posted - 2 months ago
$AXIM 🤣🤣
Inittowinits
Posted - 2 months ago
$AXIM well shit
TexasMarvL
Posted - 08/22/24
$AXIM Dual test for IgE/MMP-9. Will this test replace the existing IgE test? Cut/Paste from the 2024 Q2 10-Q. On December 13, 2022, AXIM announced the development of a novel dual IgE/MMP rapid ophthalmological diagnostic test for which the Company filed a provisional patent with the US Patent and Trademark Office. The new product offers clinicians an innovative new rapid ophthalmological diagnostic solution designed to reliably measure both Ocular Immunoglobulin E (IgE) and MMP-9 in a single test. The test is slated for further clinical development in the third quarter of 2024 and, once FDA approved, will be added to AXIM’s expanding catalog of ophthalmological diagnostic tools available to clinicians throughout North America.
TexasMarvL
Posted - 08/22/24
$AXIM The Parkinson’s disease test was mentioned only 5 times in the Q2 10-Q. 1) "We developed a tear based POC PD test"
2) "We released a video interview" where we talked about our POC PD test.
3) lastly Parkinsons was mention 3 times in 1 paragraph talking about, "We filed a patent" for our POC PD test.
UCIdidmyDD
Posted - 3 months ago
$AXIM 6000 cash left how does it work from here?
TexasMarvL
Posted - 3 months ago
$AXIM 10-Q said Q2 revenue fell off a cliff. How long has it been since Verséa Ophthalmics LinkedIn page shared a post about a new #TPOCTITAN customer? These results are a total disaster. Only 1000 tests were sold in Q2. Cut/paste
During the quarter ending March 31, 2024 4,550 in tests were shipped at $10 per test resulting in revenue recognition of $45,500 and during the quarter ended June 30, 2024 1,000 tests were shipped resulting in 10,000 revenue recognition; leaving a carrying value of $136,500. There was a verbal agreement to reduce the selling price of the tests from $12- to $10- https://www.otcmarkets.com/filing/html?id=17772267&guid=EvO-ke82wLxnB3h
Inittowinits
Posted - 3 months ago
$AXIM is the volume of 2.9 million accurate?
javanz
Posted - 3 months ago
$AXIM Doesn’t look like anybody is shedding tears for this dry eye company it does seem to bleed a lot
TexasMarvL
Posted - 3 months ago
$AXIM I still own all of my shares and I'm still watching LinkedIn and various websites for updates. AXIM and Verséa are silent right now. Nothing to report. Nothing to talk about.
TexasMarvL
Posted - 07/27/24
$AXIM Shared by Verséa Ophthalmics on their LinkedIn page today.
https://www.cornealphysician.com/issues/2024/july/detailing-dry-eye-disease-diagnostics/
TexasMarvL
Posted - 07/23/24
$AXIM I'm not pressing the bullish button, because this is very low volume AXIM. However, the 3 month chart does look like a cup and handle. Obviously there is so much negative history with this company. That stinks. There are some positive things as well over the last 8 months. New customers seem slower than expected.
TexasMarvL
Posted - 4 months ago
$AXIM #Ophthalmic #Surgical #Instruments Abdul Hanan and Company made following post yesterday on LinkedIn and copied Verséa Ophthalmics. Apparently Verséa Ophthalmics will market #Ophthalmic #Surgical #Instruments as well as their diagnostic and therapeutic solutions. Verséa Ophthalmics will apparently become a complete Ophthalmic supply company. No posts yet from Verséa Ophthalmics. https://www.linkedin.com/posts/abdul-hanan-%26-company_lid-retractors-ophthalmic-activity-7216000138144583681-h4tX?utm_source=share&utm_medium=member_android
Inittowinits
Posted - 4 months ago
$AXIM Omaha seems to be target rich environment for the team. Not the first Omaha I’ve seen.
TexasMarvL
Posted - 4 months ago
$AXIM Nice bump in share price today. Low volume but still a nice bump.
javanz
Posted - 5 months ago
$AXIM Can’t shed no tears here
TexasMarvL
Posted - 5 months ago
$AXIM Previous Post 1 of 4
In the previous post I shared a link from Verséa Health that stated Verséa Ophthalmics "Hosted a successful T-POC Implementation training in Omaha Nebraska". In this post I want to string together three posts over the last 2 months by a new customer Doctor Kyle Klute, who to date still has not been announced as a #TPOCTITAN by Verséa Ophthalmics. That announcement should be coming soon. Notice the above training was in Omaha Nebraska. At least 2 of the 4 eye doctors mentioned in these posts are based out of Omaha Nebraska. It will be interesting to watch if Verséa Ophthalmics adds more of these regional #TPOC Implementation training courses across the country. This is another way to better utilize existing resources to add more locations within a compressed amount of time.
TexasMarvL
Posted - 5 months ago
$AXIM Verséa Ophthalmics is mentioned in this Verséa Health LinkedIn post. https://www.linkedin.com/posts/verseaholdings_verseahealth-healthcareinnovation-activity-7204857792128544768-ATjw?utm_source=share&utm_medium=member_android Verséa Ophthalmics: "Hosted a successful T-POC Implementation training in Omaha Nebraska". This is good news. Hopefully the backlog of new customers starts to come online faster.
TexasMarvL
Posted - 5 months ago
$AXIM Opinions page 1 of 3
BOTTOM LINE: AXIM and MJNA insiders have control over ALL the AXIM assets. Verséa Ophthalmics is building their business on the foundation of the exclusive marketing agreement for three of the AXIM Dry Eye Disease Tear based Point-of-Care tests. MY OPINION: Personally I have been a "big" buyer below a penny in the last month or two. This is not investment advice. Penny stocks can have a high level of volatility. There is a risk of losing everything invested in AXIM. Don't invest money needed for food or rent or happiness.